Header Logo

Connection

MARGARET SPITZ to Middle Aged

Back to Details
This is a "connection" page, showing publications MARGARET SPITZ has written about Middle Aged.
MARGARET SPITZ
Connection Strength
2.057
Middle Aged
  1. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018 10; 13(10):1483-1495.
    View in: PubMed
    Score: 0.038
  2. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
    View in: PubMed
    Score: 0.032
  3. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7.
    View in: PubMed
    Score: 0.026
  4. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
    View in: PubMed
    Score: 0.025
  5. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
    View in: PubMed
    Score: 0.023
  6. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):900-11.
    View in: PubMed
    Score: 0.023
  7. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010 Aug 04; 102(15):1199-205.
    View in: PubMed
    Score: 0.022
  8. Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage. 2009 Dec; 38(6):894-902.
    View in: PubMed
    Score: 0.021
  9. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics. 2008 Nov; 18(11):955-65.
    View in: PubMed
    Score: 0.019
  10. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6.
    View in: PubMed
    Score: 0.019
  11. Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Dec 01; 178(11):1164-72.
    View in: PubMed
    Score: 0.019
  12. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):250-4.
    View in: PubMed
    Score: 0.019
  13. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila). 2008 Sep; 1(4):255-65.
    View in: PubMed
    Score: 0.019
  14. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol. 2008 Aug; 21(8):950-60.
    View in: PubMed
    Score: 0.019
  15. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81.
    View in: PubMed
    Score: 0.018
  16. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.018
  17. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007 Jul 01; 67(13):6520-7.
    View in: PubMed
    Score: 0.018
  18. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95.
    View in: PubMed
    Score: 0.017
  19. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26.
    View in: PubMed
    Score: 0.017
  20. Age-related differences in factors associated with smoking initiation. Cancer Causes Control. 2007 Aug; 18(6):635-44.
    View in: PubMed
    Score: 0.017
  21. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis. 2007 Jul; 28(7):1430-6.
    View in: PubMed
    Score: 0.017
  22. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Clin Cancer Res. 2006 Dec 01; 12(23):7194-201.
    View in: PubMed
    Score: 0.017
  23. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006 Jun 15; 66(12):6449-56.
    View in: PubMed
    Score: 0.016
  24. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr 01; 118(7):1798-804.
    View in: PubMed
    Score: 0.016
  25. An epidemiologic study of early onset lung cancer. Lung Cancer. 2006 May; 52(2):129-34.
    View in: PubMed
    Score: 0.016
  26. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79.
    View in: PubMed
    Score: 0.016
  27. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):158-61.
    View in: PubMed
    Score: 0.016
  28. Dietary phytoestrogens and lung cancer risk. JAMA. 2005 Sep 28; 294(12):1493-504.
    View in: PubMed
    Score: 0.016
  29. Wood dust exposure and the association with lung cancer risk. Am J Ind Med. 2005 Apr; 47(4):349-57.
    View in: PubMed
    Score: 0.015
  30. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol. 2005 Apr; 32(2 Suppl 3):S92-8.
    View in: PubMed
    Score: 0.015
  31. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005 Mar 01; 161(5):412-22.
    View in: PubMed
    Score: 0.015
  32. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57.
    View in: PubMed
    Score: 0.015
  33. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95.
    View in: PubMed
    Score: 0.014
  34. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):113-23.
    View in: PubMed
    Score: 0.014
  35. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res. 2003 Dec 01; 63(23):8531-5.
    View in: PubMed
    Score: 0.014
  36. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):963-9.
    View in: PubMed
    Score: 0.014
  37. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):980-6.
    View in: PubMed
    Score: 0.014
  38. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.013
  39. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003 Mar; 14(2):131-8.
    View in: PubMed
    Score: 0.013
  40. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1413-8.
    View in: PubMed
    Score: 0.013
  41. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):758-66.
    View in: PubMed
    Score: 0.012
  42. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1091-9.
    View in: PubMed
    Score: 0.012
  43. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8.
    View in: PubMed
    Score: 0.012
  44. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
    View in: PubMed
    Score: 0.012
  45. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis. 2001 Jun; 22(6):923-8.
    View in: PubMed
    Score: 0.011
  46. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001 Feb 15; 61(4):1354-7.
    View in: PubMed
    Score: 0.011
  47. Leptin and prostate cancer. Prostate. 2001 Jan 01; 46(1):62-7.
    View in: PubMed
    Score: 0.011
  48. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000 Nov 01; 92(21):1764-72.
    View in: PubMed
    Score: 0.011
  49. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1017-20.
    View in: PubMed
    Score: 0.011
  50. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1021-6.
    View in: PubMed
    Score: 0.011
  51. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.011
  52. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer. 1999 May; 80(3-4):453-7.
    View in: PubMed
    Score: 0.010
  53. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol. 2019 08; 14(8):1360-1369.
    View in: PubMed
    Score: 0.010
  54. Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):715-723.
    View in: PubMed
    Score: 0.010
  55. Case-control study of diet and prostate cancer in China. Cancer Causes Control. 1998 Dec; 9(6):545-52.
    View in: PubMed
    Score: 0.010
  56. Whole exome sequencing analysis in severe chronic obstructive pulmonary disease. Hum Mol Genet. 2018 11 01; 27(21):3801-3812.
    View in: PubMed
    Score: 0.010
  57. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer. 1998 Oct 23; 79(5):490-3.
    View in: PubMed
    Score: 0.010
  58. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1998 Sep 16; 90(18):1393-9.
    View in: PubMed
    Score: 0.010
  59. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer. 1998 Sep 15; 83(6):1118-27.
    View in: PubMed
    Score: 0.010
  60. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res. 1998 Apr 15; 58(8):1605-8.
    View in: PubMed
    Score: 0.009
  61. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998 Mar 04; 90(5):358-63.
    View in: PubMed
    Score: 0.009
  62. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 04; 90(3):243-5.
    View in: PubMed
    Score: 0.009
  63. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):13-8.
    View in: PubMed
    Score: 0.009
  64. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
    View in: PubMed
    Score: 0.009
  65. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):687-92.
    View in: PubMed
    Score: 0.009
  66. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug; 6(8):565-71.
    View in: PubMed
    Score: 0.009
  67. A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network. Cancer Epidemiol Biomarkers Prev. 1997 Jul; 6(7):537-42.
    View in: PubMed
    Score: 0.009
  68. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet. 2017 Jul; 49(7):1126-1132.
    View in: PubMed
    Score: 0.009
  69. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. Cancer. 1997 Apr 15; 79(8):1527-32.
    View in: PubMed
    Score: 0.009
  70. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996 Sep 15; 56(18):4103-7.
    View in: PubMed
    Score: 0.008
  71. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996 Sep 01; 56(17):3975-9.
    View in: PubMed
    Score: 0.008
  72. Clinical and genetic investigation of a Brazilian family with Huntington's disease. Funct Neurol. 2016 Jul-Sep; 31(3):135-42.
    View in: PubMed
    Score: 0.008
  73. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8.
    View in: PubMed
    Score: 0.008
  74. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 1995 Sep; 4(6):583-8.
    View in: PubMed
    Score: 0.008
  75. Lower lung cancer rates in Jewish smokers in Israel and the USA. Int J Cancer. 2015 Nov 01; 137(9):2155-62.
    View in: PubMed
    Score: 0.008
  76. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.008
  77. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97.
    View in: PubMed
    Score: 0.007
  78. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
    View in: PubMed
    Score: 0.007
  79. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res. 1995 Feb 01; 55(3):557-61.
    View in: PubMed
    Score: 0.007
  80. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr. 1995; (18):29-33.
    View in: PubMed
    Score: 0.007
  81. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis. 2015 Jan; 36(1):99-103.
    View in: PubMed
    Score: 0.007
  82. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
    View in: PubMed
    Score: 0.007
  83. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2462-70.
    View in: PubMed
    Score: 0.007
  84. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014 Dec; 14(6):509-22.
    View in: PubMed
    Score: 0.007
  85. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis. 1994 Jun; 15(6):1121-4.
    View in: PubMed
    Score: 0.007
  86. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369.
    View in: PubMed
    Score: 0.007
  87. Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health. 2013 Oct; 15(5):910-7.
    View in: PubMed
    Score: 0.007
  88. Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer. 2013 Nov; 21(11):3117-25.
    View in: PubMed
    Score: 0.007
  89. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug; 2(4):329-33.
    View in: PubMed
    Score: 0.007
  90. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.007
  91. Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog. 2014 Jul; 53(7):548-56.
    View in: PubMed
    Score: 0.007
  92. Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. Int J Mol Sci. 2013 Apr 16; 14(4):8381-92.
    View in: PubMed
    Score: 0.007
  93. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013 05; 132(5):579-89.
    View in: PubMed
    Score: 0.006
  94. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One. 2013; 8(1):e53475.
    View in: PubMed
    Score: 0.006
  95. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.006
  96. Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):135-45.
    View in: PubMed
    Score: 0.006
  97. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013 Aug; 46(2):161-72.
    View in: PubMed
    Score: 0.006
  98. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013 Jan 01; 73(1):256-64.
    View in: PubMed
    Score: 0.006
  99. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91.
    View in: PubMed
    Score: 0.006
  100. Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA). Addict Behav. 2013 Jan; 38(1):1485-92.
    View in: PubMed
    Score: 0.006
  101. Chapter 11: Rice-MD Anderson lung cancer model. Risk Anal. 2012 Jul; 32 Suppl 1:S142-50.
    View in: PubMed
    Score: 0.006
  102. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis. 2012 Aug; 33(8):1531-7.
    View in: PubMed
    Score: 0.006
  103. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.006
  104. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
    View in: PubMed
    Score: 0.006
  105. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012 May 16; 104(10):778-89.
    View in: PubMed
    Score: 0.006
  106. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012 Sep; 48(13):1957-68.
    View in: PubMed
    Score: 0.006
  107. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control. 2012 Mar; 23(3):487-96.
    View in: PubMed
    Score: 0.006
  108. Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One. 2012; 7(2):e31816.
    View in: PubMed
    Score: 0.006
  109. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012 May 15; 175(10):1013-20.
    View in: PubMed
    Score: 0.006
  110. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol. 2012 Mar; 138(3):377-85.
    View in: PubMed
    Score: 0.006
  111. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2603-9.
    View in: PubMed
    Score: 0.006
  112. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71.
    View in: PubMed
    Score: 0.006
  113. DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. J Clin Oncol. 2011 Nov 01; 29(31):4121-8.
    View in: PubMed
    Score: 0.006
  114. Activating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. Ann Thorac Surg. 2011 Sep; 92(3):1044-50.
    View in: PubMed
    Score: 0.006
  115. Dietary patterns affect lung cancer risk in never smokers. Nutr Cancer. 2011; 63(6):842-9.
    View in: PubMed
    Score: 0.006
  116. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9.
    View in: PubMed
    Score: 0.006
  117. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011 Sep 07; 103(17):1342-6.
    View in: PubMed
    Score: 0.006
  118. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.006
  119. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6.
    View in: PubMed
    Score: 0.006
  120. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25.
    View in: PubMed
    Score: 0.006
  121. A smoking-based carcinogenesis model for lung cancer risk prediction. Int J Cancer. 2011 Oct 15; 129(8):1907-13.
    View in: PubMed
    Score: 0.006
  122. An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. DNA Repair (Amst). 2011 Apr 03; 10(4):398-407.
    View in: PubMed
    Score: 0.006
  123. Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
    View in: PubMed
    Score: 0.006
  124. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila). 2011 Feb; 4(2):185-93.
    View in: PubMed
    Score: 0.006
  125. Risk profiles of women with cervical neoplasia. J Cancer Educ. 1991; 6(4):241-6.
    View in: PubMed
    Score: 0.006
  126. Variants in folate pathway genes as modulators of genetic instability and lung cancer risk. Genes Chromosomes Cancer. 2011 Jan; 50(1):1-12.
    View in: PubMed
    Score: 0.006
  127. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011 Mar; 32(3):312-7.
    View in: PubMed
    Score: 0.006
  128. Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg. 1990 Oct; 116(10):1163-6.
    View in: PubMed
    Score: 0.005
  129. Leukemia and cigarette smoking. Cancer Causes Control. 1990 Sep; 1(2):195-6.
    View in: PubMed
    Score: 0.005
  130. Assessing environmental and occupational risk factors for lung cancer in Mexican-Americans. Cancer Causes Control. 2010 Dec; 21(12):2157-64.
    View in: PubMed
    Score: 0.005
  131. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402.
    View in: PubMed
    Score: 0.005
  132. Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers. BMC Cancer. 2010 Aug 18; 10:439.
    View in: PubMed
    Score: 0.005
  133. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 2010 Aug 05; 6(8).
    View in: PubMed
    Score: 0.005
  134. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010 Jul 15; 116(14):3458-62.
    View in: PubMed
    Score: 0.005
  135. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
    View in: PubMed
    Score: 0.005
  136. A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer. Clin Cancer Res. 2010 Jul 15; 16(14):3779-85.
    View in: PubMed
    Score: 0.005
  137. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer. 2011 Jan; 71(1):82-8.
    View in: PubMed
    Score: 0.005
  138. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 2010 Apr; 11(4):321-30.
    View in: PubMed
    Score: 0.005
  139. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.005
  140. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J Cancer Educ. 1990; 5(2):109-13.
    View in: PubMed
    Score: 0.005
  141. Cigarette smoking patterns of cancer patients. Prog Clin Biol Res. 1990; 339:73-82.
    View in: PubMed
    Score: 0.005
  142. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2636-42.
    View in: PubMed
    Score: 0.005
  143. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989 Aug 15; 49(16):4626-8.
    View in: PubMed
    Score: 0.005
  144. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009 Aug 15; 69(16):6633-41.
    View in: PubMed
    Score: 0.005
  145. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009 May; 49(5):1563-70.
    View in: PubMed
    Score: 0.005
  146. Encouraging trends in lung cancer mortality in Texas, 1970 to 1986. Tex Med. 1989 Mar; 85(3):42-4.
    View in: PubMed
    Score: 0.005
  147. Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge. J Cancer Educ. 2009; 24(1):58-64.
    View in: PubMed
    Score: 0.005
  148. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95.
    View in: PubMed
    Score: 0.005
  149. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3081-9.
    View in: PubMed
    Score: 0.005
  150. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer. 1988 Oct 15; 42(4):549-53.
    View in: PubMed
    Score: 0.005
  151. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer. 2008 Oct 15; 123(8):1883-91.
    View in: PubMed
    Score: 0.005
  152. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep 01; 123(5):1173-80.
    View in: PubMed
    Score: 0.005
  153. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol. 2008 Sep; 3(9):979-84.
    View in: PubMed
    Score: 0.005
  154. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. Cancer Detect Prev. 2008; 32(2):101-8.
    View in: PubMed
    Score: 0.005
  155. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11.
    View in: PubMed
    Score: 0.005
  156. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer. 2008 Jun 15; 112(12):2756-64.
    View in: PubMed
    Score: 0.005
  157. Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res. 2008 Jun 01; 68(11):4479-85.
    View in: PubMed
    Score: 0.005
  158. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1322-8.
    View in: PubMed
    Score: 0.005
  159. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1111-9.
    View in: PubMed
    Score: 0.005
  160. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008 May; 29(5):949-56.
    View in: PubMed
    Score: 0.005
  161. Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer. Br J Cancer. 2008 May 20; 98(10):1716-22.
    View in: PubMed
    Score: 0.005
  162. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008 May; 40(5):616-22.
    View in: PubMed
    Score: 0.005
  163. Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. Am J Epidemiol. 2008 May 01; 167(9):1070-80.
    View in: PubMed
    Score: 0.005
  164. Profiles of cigarette smoking among patients in a cancer center. J Cancer Educ. 1988; 3(4):265-71.
    View in: PubMed
    Score: 0.005
  165. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer. 1988 Jan 01; 61(1):203-8.
    View in: PubMed
    Score: 0.005
  166. ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer. 2007 Nov 15; 121(10):2254-9.
    View in: PubMed
    Score: 0.004
  167. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res. 2007 Oct 01; 13(19):5974-81.
    View in: PubMed
    Score: 0.004
  168. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):2065-71.
    View in: PubMed
    Score: 0.004
  169. Seizure 6-like (SEZ6L) gene and risk for lung cancer. Cancer Res. 2007 Sep 01; 67(17):8406-11.
    View in: PubMed
    Score: 0.004
  170. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007 Aug 15; 110(4):867-75.
    View in: PubMed
    Score: 0.004
  171. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8.
    View in: PubMed
    Score: 0.004
  172. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22.
    View in: PubMed
    Score: 0.004
  173. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8.
    View in: PubMed
    Score: 0.004
  174. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer. 2007 Aug; 57(2):143-51.
    View in: PubMed
    Score: 0.004
  175. Birthplace, years of residence in the United States, and obesity among Mexican-American adults. Obesity (Silver Spring). 2007 Apr; 15(4):1043-52.
    View in: PubMed
    Score: 0.004
  176. Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study. Cancer. 2007 Mar 15; 109(6):1157-63.
    View in: PubMed
    Score: 0.004
  177. Dietary zinc, copper and selenium, and risk of lung cancer. Int J Cancer. 2007 Mar 01; 120(5):1108-15.
    View in: PubMed
    Score: 0.004
  178. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9.
    View in: PubMed
    Score: 0.004
  179. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Dec 15; 12(24):7329-38.
    View in: PubMed
    Score: 0.004
  180. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2364-9.
    View in: PubMed
    Score: 0.004
  181. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis. 2007 May; 28(5):988-94.
    View in: PubMed
    Score: 0.004
  182. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Oct 01; 12(19):5720-5.
    View in: PubMed
    Score: 0.004
  183. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1935-40.
    View in: PubMed
    Score: 0.004
  184. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.004
  185. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5.
    View in: PubMed
    Score: 0.004
  186. Bladder cancer risk as modified by family history and smoking. Cancer. 2006 Aug 15; 107(4):705-11.
    View in: PubMed
    Score: 0.004
  187. Human sensitivity to PhIP: a novel marker for prostate cancer risk. Mutat Res. 2006 Oct 10; 601(1-2):1-10.
    View in: PubMed
    Score: 0.004
  188. Lung and breast cancer death rates in Texas women. Tex Med. 1986 Aug; 82(8):44-6.
    View in: PubMed
    Score: 0.004
  189. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer. 2006 Jun 15; 106(12):2636-44.
    View in: PubMed
    Score: 0.004
  190. MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006 Oct; 27(10):2028-33.
    View in: PubMed
    Score: 0.004
  191. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7.
    View in: PubMed
    Score: 0.004
  192. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):441-7.
    View in: PubMed
    Score: 0.004
  193. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.004
  194. Questionable relationship between cholecystectomy and colon cancer. J Surg Oncol. 1985 Sep; 30(1):6-9.
    View in: PubMed
    Score: 0.004
  195. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):547-55.
    View in: PubMed
    Score: 0.004
  196. Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):557-64.
    View in: PubMed
    Score: 0.004
  197. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5.
    View in: PubMed
    Score: 0.004
  198. Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. J Clin Oncol. 2005 Jul 01; 23(19):4439-49.
    View in: PubMed
    Score: 0.004
  199. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6.
    View in: PubMed
    Score: 0.004
  200. Neuroblastoma and paternal occupation. A case-control analysis. Am J Epidemiol. 1985 Jun; 121(6):924-9.
    View in: PubMed
    Score: 0.004
  201. Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. Am J Public Health. 2005 Jun; 95(6):1043-9.
    View in: PubMed
    Score: 0.004
  202. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1477-84.
    View in: PubMed
    Score: 0.004
  203. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6.
    View in: PubMed
    Score: 0.004
  204. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis. 2005 Oct; 26(10):1741-7.
    View in: PubMed
    Score: 0.004
  205. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005 Sep; 26(9):1596-602.
    View in: PubMed
    Score: 0.004
  206. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg. 2005 May; 79(5):1704-10.
    View in: PubMed
    Score: 0.004
  207. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1188-93.
    View in: PubMed
    Score: 0.004
  208. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res. 2005 Apr 15; 11(8):2894-8.
    View in: PubMed
    Score: 0.004
  209. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005 Apr 04; 582(1-2):71-8.
    View in: PubMed
    Score: 0.004
  210. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):878-84.
    View in: PubMed
    Score: 0.004
  211. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1034-6.
    View in: PubMed
    Score: 0.004
  212. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):748-52.
    View in: PubMed
    Score: 0.004
  213. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics. 2005 Mar; 15(3):159-65.
    View in: PubMed
    Score: 0.004
  214. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer. 2005; 53(2):127-34.
    View in: PubMed
    Score: 0.004
  215. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51.
    View in: PubMed
    Score: 0.004
  216. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89.
    View in: PubMed
    Score: 0.004
  217. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):330-8.
    View in: PubMed
    Score: 0.004
  218. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9.
    View in: PubMed
    Score: 0.004
  219. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004 Dec 01; 10(23):7903-10.
    View in: PubMed
    Score: 0.004
  220. Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet. 2005 Jan; 116(1-2):121-7.
    View in: PubMed
    Score: 0.004
  221. Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer. 1984 Nov 01; 54(9):1854-9.
    View in: PubMed
    Score: 0.004
  222. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004 Oct 01; 64(19):6863-6.
    View in: PubMed
    Score: 0.004
  223. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate. 2004 Sep 01; 60(4):343-51.
    View in: PubMed
    Score: 0.004
  224. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002.
    View in: PubMed
    Score: 0.004
  225. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.004
  226. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1081-3.
    View in: PubMed
    Score: 0.004
  227. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep; 25(9):1639-47.
    View in: PubMed
    Score: 0.004
  228. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81.
    View in: PubMed
    Score: 0.003
  229. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984 Jan; 110(1):45-9.
    View in: PubMed
    Score: 0.003
  230. p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol. 2003 Dec; 121(6):1510-4.
    View in: PubMed
    Score: 0.003
  231. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003 Oct 20; 107(1):84-8.
    View in: PubMed
    Score: 0.003
  232. XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer. 2003 Oct 15; 98(8):1701-6.
    View in: PubMed
    Score: 0.003
  233. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003 Oct 01; 98(7):1457-64.
    View in: PubMed
    Score: 0.003
  234. Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer. 2003 Oct; 42(1):1-8.
    View in: PubMed
    Score: 0.003
  235. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.003
  236. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7.
    View in: PubMed
    Score: 0.003
  237. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr 02; 95(7):540-7.
    View in: PubMed
    Score: 0.003
  238. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003 Apr; 40(1):25-32.
    View in: PubMed
    Score: 0.003
  239. Death receptor 4 and bladder cancer risk. Cancer Res. 2003 Mar 15; 63(6):1157-9.
    View in: PubMed
    Score: 0.003
  240. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis. Mol Carcinog. 2003 Mar; 36(3):123-9.
    View in: PubMed
    Score: 0.003
  241. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.003
  242. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7.
    View in: PubMed
    Score: 0.003
  243. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer. Int J Cancer. 2002 Dec 10; 102(5):536-40.
    View in: PubMed
    Score: 0.003
  244. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1142-3.
    View in: PubMed
    Score: 0.003
  245. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002 Sep 26; 183(2):123-30.
    View in: PubMed
    Score: 0.003
  246. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002 Sep 01; 62(17):4992-5.
    View in: PubMed
    Score: 0.003
  247. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1084-8.
    View in: PubMed
    Score: 0.003
  248. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. Cancer. 2002 Aug 01; 95(3):563-8.
    View in: PubMed
    Score: 0.003
  249. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer. 2002 Jul; 37(1):35-40.
    View in: PubMed
    Score: 0.003
  250. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):640-5.
    View in: PubMed
    Score: 0.003
  251. XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol. 2002 Jul; 38(5):475-7.
    View in: PubMed
    Score: 0.003
  252. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul; 42(1):29-37.
    View in: PubMed
    Score: 0.003
  253. Genetic instability of specific chromosomes associated with a family history of cancer. Cancer Genet Cytogenet. 2002 Jul 01; 136(1):73-7.
    View in: PubMed
    Score: 0.003
  254. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
    View in: PubMed
    Score: 0.003
  255. Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. Lung Cancer. 2002 Jun; 36(3):243-7.
    View in: PubMed
    Score: 0.003
  256. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 2002 Feb; 35(2):137-42.
    View in: PubMed
    Score: 0.003
  257. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002 Jan 15; 94(2):393-7.
    View in: PubMed
    Score: 0.003
  258. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res. 2001 Dec 01; 61(23):8465-9.
    View in: PubMed
    Score: 0.003
  259. Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. Carcinogenesis. 2001 Dec; 22(12):2005-8.
    View in: PubMed
    Score: 0.003
  260. Evaluation of Mexican American migrant farmworker work practices and organochlorine pesticide metabolites. Am J Ind Med. 2001 Nov; 40(5):554-60.
    View in: PubMed
    Score: 0.003
  261. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res. 2001 Nov 01; 61(21):7819-24.
    View in: PubMed
    Score: 0.003
  262. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001 Nov 01; 61(21):7825-9.
    View in: PubMed
    Score: 0.003
  263. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001 Sep 20; 95(5):332-6.
    View in: PubMed
    Score: 0.003
  264. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control. 2001 Sep; 12(7):627-33.
    View in: PubMed
    Score: 0.003
  265. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer. 2001 Aug 01; 93(3):436-40.
    View in: PubMed
    Score: 0.003
  266. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001 Aug; 22(8):1195-9.
    View in: PubMed
    Score: 0.003
  267. The development of breast carcinoma in women with thyroid carcinoma. Cancer. 2001 Jul 15; 92(2):225-31.
    View in: PubMed
    Score: 0.003
  268. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study. Prostate. 2001 Jun 01; 47(4):269-75.
    View in: PubMed
    Score: 0.003
  269. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res. 2001 Apr 15; 61(8):3321-5.
    View in: PubMed
    Score: 0.003
  270. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):397-401.
    View in: PubMed
    Score: 0.003
  271. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):273-5.
    View in: PubMed
    Score: 0.003
  272. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res. 2001 Feb 15; 61(4):1445-50.
    View in: PubMed
    Score: 0.003
  273. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000 Dec; 21(12):2219-23.
    View in: PubMed
    Score: 0.003
  274. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000 Nov 15; 88(4):601-6.
    View in: PubMed
    Score: 0.003
  275. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1043-9.
    View in: PubMed
    Score: 0.003
  276. Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol. 2000 Aug; 17(2):399-404.
    View in: PubMed
    Score: 0.003
  277. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis. 2000 Aug; 21(8):1527-30.
    View in: PubMed
    Score: 0.003
  278. Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res. 2000 Jul; 154(1):20-7.
    View in: PubMed
    Score: 0.003
  279. Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog. 2000 Jan; 27(1):34-46.
    View in: PubMed
    Score: 0.003
  280. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1071-8.
    View in: PubMed
    Score: 0.003
  281. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett. 1999 Nov 01; 146(1):93-101.
    View in: PubMed
    Score: 0.003
  282. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis. 1999 Aug; 20(8):1465-9.
    View in: PubMed
    Score: 0.003
  283. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer. 1999 Jun 21; 84(3):220-4.
    View in: PubMed
    Score: 0.003
  284. Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet. 1999 Apr; 110(1):65-9.
    View in: PubMed
    Score: 0.002
  285. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20; 91(2):151-6.
    View in: PubMed
    Score: 0.002
  286. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999; 33(1):20-5.
    View in: PubMed
    Score: 0.002
  287. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 1998 Jul 15; 83(2):204-12.
    View in: PubMed
    Score: 0.002
  288. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998 Jul; 4(7):1773-8.
    View in: PubMed
    Score: 0.002
  289. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 1998 Jul; 7(7):567-70.
    View in: PubMed
    Score: 0.002
  290. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1998 Jun; 7(6):465-8.
    View in: PubMed
    Score: 0.002
  291. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 1998 Apr; 7(4):309-14.
    View in: PubMed
    Score: 0.002
  292. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leuk Lymphoma. 1998 Feb; 28(5-6):561-6.
    View in: PubMed
    Score: 0.002
  293. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control. 1997 Jul; 8(4):554-9.
    View in: PubMed
    Score: 0.002
  294. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients. Cancer Epidemiol Biomarkers Prev. 1997 Apr; 6(4):291-3.
    View in: PubMed
    Score: 0.002
  295. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997 Feb; 6(2):87-92.
    View in: PubMed
    Score: 0.002
  296. Lung carcinoma in former smokers. Cancer. 1996 Sep 01; 78(5):1004-10.
    View in: PubMed
    Score: 0.002
  297. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res. 1996 Aug 15; 56(16):3638-41.
    View in: PubMed
    Score: 0.002
  298. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev. 1996 Aug; 5(8):639-44.
    View in: PubMed
    Score: 0.002
  299. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients. Anticancer Res. 1996 May-Jun; 16(3A):1187-92.
    View in: PubMed
    Score: 0.002
  300. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996 Apr 17; 88(8):530-5.
    View in: PubMed
    Score: 0.002
  301. Sex chromosome abnormalities in lung cancer patients. Cancer Genet Cytogenet. 1996 Mar; 87(1):24-8.
    View in: PubMed
    Score: 0.002
  302. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov; 4(7):743-9.
    View in: PubMed
    Score: 0.002
  303. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995 Aug 15; 55(16):3604-9.
    View in: PubMed
    Score: 0.002
  304. Vasectomy and prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 1994 Jun; 3(4):285-8.
    View in: PubMed
    Score: 0.002
  305. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr; 2(2):103-6.
    View in: PubMed
    Score: 0.002
  306. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med. 1993 Mar; 22(3):101-8.
    View in: PubMed
    Score: 0.002
  307. Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control. 1992 Jul; 3(4):377-82.
    View in: PubMed
    Score: 0.002
  308. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst. 1990 Nov 21; 82(22):1773-5.
    View in: PubMed
    Score: 0.001
  309. A case-control study of prostate cancer. Am J Epidemiol. 1989 Aug; 130(2):395-8.
    View in: PubMed
    Score: 0.001
  310. Cancer and age. Semin Oncol. 1989 Feb; 16(1):3-9.
    View in: PubMed
    Score: 0.001
  311. Subfertility: an etiologic factor in development of testicular cancer? Urology. 1987 Sep; 30(3):199-200.
    View in: PubMed
    Score: 0.001
  312. Incidence of prostate cancer and marital status. J Natl Cancer Inst. 1987 Aug; 79(2):259-62.
    View in: PubMed
    Score: 0.001
  313. Incidence of testicular cancer in the United States related to marital status, histology, and ethnicity. J Natl Cancer Inst. 1987 May; 78(5):881-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.